Free Trial

Exelixis (EXEL) News Today

→ Time is Running Out - June 25th Deadline Approaching! (From Paradigm Press) (Ad)
Free EXEL Stock Alerts
$21.88
-0.30 (-1.35%)
(As of 06/7/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends
June 7 at 11:02 AM | stocknews.com
3 Popular Biotech Stocks Offering Solid June Returns
June 7 at 9:38 AM | marketbeat.com
Pinebridge Investments L.P. Buys 302,370 Shares of Exelixis, Inc. (NASDAQ:EXEL)
Pinebridge Investments L.P. raised its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 1,026.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 331,831 shares of the biotechnology company's stock after acquiring an additi
June 7 at 8:26 AM | americanbankingnews.com
Exelixis, Inc. (NASDAQ:EXEL) Director Jack L. Wyszomierski Sells 8,287 Shares of Stock
June 7 at 8:23 AM | insidertrades.com
Insider Selling: Exelixis, Inc. (NASDAQ:EXEL) Director Sells 8,287 Shares of Stock
June 7 at 4:01 AM | gurufocus.com
Insider Sale: Director Jack Wyszomierski Sells Shares of Exelixis Inc (EXEL)
June 6 at 10:07 PM | marketbeat.com
Exelixis, Inc. (NASDAQ:EXEL) Director Sells $182,314.00 in Stock
Exelixis, Inc. (NASDAQ:EXEL - Get Free Report) Director Jack L. Wyszomierski sold 8,287 shares of the firm's stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $22.00, for a total transaction of $182,314.00. Following the completion of the transaction, the director now directly owns 349,499 shares in the company, valued at $7,688,978. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
June 6 at 1:36 AM | americanbankingnews.com
StockNews.com Downgrades Exelixis (NASDAQ:EXEL) to Buy
June 4, 2024 | marketbeat.com
Exelixis (NASDAQ:EXEL) Stock Rating Lowered by StockNews.com
StockNews.com cut shares of Exelixis from a "strong-buy" rating to a "buy" rating in a report on Tuesday.
June 3, 2024 | marketbeat.com
Exelixis, Inc. (NASDAQ:EXEL) is Stephens Investment Management Group LLC's 8th Largest Position
Stephens Investment Management Group LLC reduced its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 2.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,106,664 shares of the biotechnology company's stock after selling
June 2, 2024 | 247wallst.com
Insider Buying Heats Up at Fracker, Aircraft and Boat Makers, and More
June 2, 2024 | americanbankingnews.com
Exelixis (NASDAQ:EXEL) Shares Gap Up on Insider Buying Activity
June 1, 2024 | americanbankingnews.com
David Edward Johnson Purchases 200,000 Shares of Exelixis, Inc. (NASDAQ:EXEL) Stock
June 1, 2024 | americanbankingnews.com
Exelixis, Inc. (NASDAQ:EXEL) Director Buys 225,000 Shares
May 31, 2024 | insidertrades.com
David Edward Johnson Buys 200,000 Shares of Exelixis, Inc. (NASDAQ:EXEL) Stock
May 31, 2024 | insidertrades.com
Insider Buying: Exelixis, Inc. (NASDAQ:EXEL) Director Acquires 225,000 Shares of Stock
May 31, 2024 | marketbeat.com
Cambridge Investment Research Advisors Inc. Purchases 152,370 Shares of Exelixis, Inc. (NASDAQ:EXEL)
Cambridge Investment Research Advisors Inc. increased its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 1,125.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 165,905 shares of the biotechnolo
May 30, 2024 | marketbeat.com
Franklin Resources Inc. Has $10.42 Million Holdings in Exelixis, Inc. (NASDAQ:EXEL)
Franklin Resources Inc. raised its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 23.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 434,471 shares of the biotechnology company's stock after acquiring an additional 82,9
May 28, 2024 | businesswire.com
Exelixis to Present at the William Blair 44th Annual Growth Stock Conference
May 27, 2024 | marketbeat.com
3,061,647 Shares in Exelixis, Inc. (NASDAQ:EXEL) Purchased by Norges Bank
Norges Bank acquired a new stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 3,061,647 shares of the biotechnology company's stock, valued at approximately $73,449,000. Norges Bank owned app
May 26, 2024 | marketbeat.com
Exelixis, Inc. (NASDAQ:EXEL) Stock Position Lowered by Amalgamated Bank
Amalgamated Bank decreased its position in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 27.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 168,482 shares of the biotechnology company's stock after sell
May 25, 2024 | marketbeat.com
Exelixis, Inc. (NASDAQ:EXEL) Given Average Recommendation of "Moderate Buy" by Brokerages
Exelixis, Inc. (NASDAQ:EXEL - Get Free Report) has earned a consensus rating of "Moderate Buy" from the seventeen research firms that are presently covering the company, Marketbeat.com reports. Seven research analysts have rated the stock with a hold rating and ten have given a buy rating to the c
May 24, 2024 | benzinga.com
Director At Exelixis Sells $576K Of Stock
May 24, 2024 | marketbeat.com
Panagora Asset Management Inc. Sells 37,636 Shares of Exelixis, Inc. (NASDAQ:EXEL)
Panagora Asset Management Inc. decreased its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 50.1% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 37,530 shares of the biotechnology company's s
May 24, 2024 | finance.yahoo.com
Director Julie Smith Sells 27,280 Shares of Exelixis Inc (EXEL)
May 23, 2024 | insidertrades.com
Exelixis, Inc. (NASDAQ:EXEL) Director George Poste Sells 11,686 Shares
May 22, 2024 | marketbeat.com
Trexquant Investment LP Has $5.26 Million Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)
Trexquant Investment LP trimmed its position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 51.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 219,347 shares of the
May 21, 2024 | markets.businessinsider.com
Buy Rating for Exelixis: Navigating Patent Lifecycles and Bolstering Growth with a Robust Pipeline
May 20, 2024 | markets.businessinsider.com
Exelixis Resolves Two CABOMETYX Patent Disputes With Cipla
May 20, 2024 | businesswire.com
Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
May 20, 2024 | marketbeat.com
Jump Financial LLC Sells 127,788 Shares of Exelixis, Inc. (NASDAQ:EXEL)
Jump Financial LLC trimmed its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 79.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 32,210 shares of the biotechnology company's stock after sellin
May 17, 2024 | marketbeat.com
Exelixis, Inc. (NASDAQ:EXEL) Short Interest Up 11.0% in April
Exelixis, Inc. (NASDAQ:EXEL - Get Free Report) saw a significant growth in short interest during the month of April. As of April 30th, there was short interest totalling 9,570,000 shares, a growth of 11.0% from the April 15th total of 8,620,000 shares. Currently, 3.4% of the company's shares are short sold. Based on an average daily trading volume, of 2,380,000 shares, the short-interest ratio is presently 4.0 days.
May 17, 2024 | marketbeat.com
Exelixis, Inc. (NASDAQ:EXEL) Shares Bought by BNP Paribas Financial Markets
BNP Paribas Financial Markets increased its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 88.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 450,097 shares of the biotechnology company'
May 16, 2024 | insidertrades.com
Insider Selling: Exelixis, Inc. (NASDAQ:EXEL) Director Sells 10,923 Shares of Stock
May 15, 2024 | msn.com
Stephens & Co. Initiates Coverage of Exelixis (EXEL) with Equal-Weight Recommendation
May 14, 2024 | stocknews.com
3 A-Rated Biotech Stocks for Long-Term Investors
May 14, 2024 | marketbeat.com
Exelixis (NASDAQ:EXEL) Now Covered by Analysts at Stephens
Stephens began coverage on shares of Exelixis in a report on Tuesday. They issued an "equal weight" rating and a $23.00 price target on the stock.
May 12, 2024 | marketbeat.com
Seizert Capital Partners LLC Sells 43,339 Shares of Exelixis, Inc. (NASDAQ:EXEL)
Seizert Capital Partners LLC lessened its holdings in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 9.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 420,335 shares of the biot
May 12, 2024 | fool.com
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
May 11, 2024 | msn.com
Exelixis files patent suit against India’s Cipla over Cabometyx generics
May 11, 2024 | marketbeat.com
Swiss National Bank Decreases Stock Holdings in Exelixis, Inc. (NASDAQ:EXEL)
Swiss National Bank lessened its stake in Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 12.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 564,700 shares of the biotechnology company's stock after selling 79,500 sh
May 10, 2024 | marketwatch.com
Exelixis Files Patent Complaint Against Cipla's Cancer Treatment
May 9, 2024 | marketbeat.com
LSV Asset Management Sells 879,211 Shares of Exelixis, Inc. (NASDAQ:EXEL)
LSV Asset Management trimmed its stake in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) by 84.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 158,429 shares of the biotechnology company's stock after sel
May 7, 2024 | businesswire.com
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
May 4, 2024 | marketbeat.com
Summit Global Investments Purchases Shares of 38,458 Exelixis, Inc. (NASDAQ:EXEL)
Summit Global Investments purchased a new position in shares of Exelixis, Inc. (NASDAQ:EXEL - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 38,458 shares of the biotechnology company's stock, valued at approximately $923
May 3, 2024 | markets.businessinsider.com
Buy Rating Affirmed for Exelixis Amid Solid Revenue and Strategic Growth Initiatives
May 3, 2024 | marketbeat.com
HC Wainwright Reiterates "Buy" Rating for Exelixis (NASDAQ:EXEL)
HC Wainwright reissued a "buy" rating and issued a $28.00 price objective on shares of Exelixis in a report on Friday.
May 3, 2024 | marketbeat.com
William Blair Comments on Exelixis, Inc.'s Q3 2024 Earnings (NASDAQ:EXEL)
Exelixis, Inc. (NASDAQ:EXEL - Free Report) - Equities research analysts at William Blair decreased their Q3 2024 EPS estimates for Exelixis in a research report issued on Wednesday, May 1st. William Blair analyst A. Hsieh now expects that the biotechnology company will earn $0.27 per share for th
May 2, 2024 | markets.businessinsider.com
Hold Rating on Exelixis: Analyzing Q1 Revenue Shortfalls and Pipeline Progress
May 2, 2024 | seekingalpha.com
Exelixis: With Patent Litigation Decision Due Soon, There Are Options
May 2, 2024 | finance.yahoo.com
Exelixis, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Get Exelixis News Delivered to You Automatically

Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter.

The new masters of energy (Ad)

According to one source, this new grid could soon provide energy to “one billion people in the world who don’t have access to electricity right now.” And early investors could make a fortune.

Click here to get all the details.

EXEL Media Mentions By Week

EXEL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EXEL
News Sentiment
▼
0.90

0.73
▲
Average
Medical
News Sentiment

EXEL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EXEL Articles
This Week
▼
14

8
▲
EXEL Articles
Average Week

Get Exelixis News Delivered to You Automatically

Sign up to receive the latest news and ratings for EXEL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:EXEL) was last updated on 6/8/2024 by MarketBeat.com Staff

From Our Partners
Millionaire-Making “Wealth Pattern” Just Repeated on April 22
If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.
Paradigm Press | Sponsored
Breaking - The US Gov. Seized CITGO
Do you want an investment that can double or triple your money in the next three months? The US Court is cu...
Augury Research | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
AI Hell Will Break Loose [June 30, 2024] …
On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...
Banyan Hill Publishing | Sponsored
Was the Great Financial Crisis fun?
The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...
Brooks Enterprises | Sponsored
Collapse of the Petrodollar
The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...
Colonial Metals | Sponsored